Graf Akcie ALT (Altimmune Inc). Diskuze k akciím ALT. Aktuální informace ALT.

Základní informace o společnosti Altimmune Inc (Akcie ALT)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 463.83M
Hodnota podniku (EV) N/A
Tržby 6.226M
EBITDA N/A
Zisk -68.08
Růst v tržbách Q/Q -80.93 %
Růst v tržbách Y/Y 49.87 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.26
EV/Sales 62.47
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 74.50
P/FCF N/A
Price/Book 2.05
Účetní hodnota na akcii 5.88
Hotovost na akcii 5.62
FCF vůči ceně -15.84 %
Počet zaměstnanců 43
Tržba na zaměstnance 144.787k
Profit margin -599.20 %
Operating margin -1,105.06 %
Gross margin 100.00 %
EBIT margin -1,102.45 %
EBITDA margin -258.18 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -36.17 %
EPS - Očekávaný růst příští rok -27.78 %
Return on assets -27.24 %
Return on equity -29.82 %
ROIC -36.40 %
ROCE -27.66 %
Dluhy/Equity 0.09
Čistý dluh/EBITDA 21.42
Current ratio 26.23
Quick Ratio 26.23
Volatilita 7.37
Beta 1.16
RSI 39.78
Cílová cena analytiků 46
Známka akcie (dle analytiků) 1.00
Insider ownership 6.21 %
Institutional ownership 64.74 %
Počet akcií 39.706M
Procento shortovaných akcií 15.73 %
Short ratio 1.40 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2005
Země United States

Finanční výsledky akcie ALT

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$5.801$10.331$10.738$3.236$10.641$10.19
Cost Of Goods Sold------
Gross Profit$5.801$10.331$10.738$3.236$10.641$10.19
Research And Development Expenses$17.766$18.459$18.406$7.222$5.134$9.32
SG&A Expenses$8.501$9.766$8.458$7.106$6.222$10.912
Other Operating Income Or Expenses------
Operating Expenses$27.266$53.166$62.784$14.328$14.044$20.382
Operating Income$-21.465$-42.834$-52.045$-11.092$-3.403$-10.191
Total Non-Operating Income/Expense$0.886$-2.487$-0.019$0.005$0.024$0.298
Pre-Tax Income$-20.579$-45.321$-52.064$-11.087$-3.379$-9.894
Income Taxes$-0.059$-6.15$-5.638-$0.062$0.062
Income After Taxes$-20.52$-39.171$-46.425$-11.087$-3.441$-9.955
Other Income------
Income From Continuous Operations$-20.52$-39.171$-46.425$-11.087$-3.441$-9.955
Income From Discontinued Operations------
Net Income$-20.973$-42.479$-51.355$-11.455$-3.441$-9.955
EBITDA$-20.078$-17.591$-15.987$-10.956$-3.261$-10.041
EBIT$-21.465$-42.834$-52.045$-11.092$-3.403$-10.191
Basic Shares Outstanding1330000
Shares Outstanding1330000
Basic EPS$-1.60$-15.16$-118.91$-49.85$-15.02$-51.05
EPS - Earnings Per Share$-1.60$-15.16$-118.91$-49.85$-15.02$-51.05
# 2020 2019 2018 2017 2016 2015
Current Ratio10.0428.69646.11140.82027.90437.4563
Long-term Debt / Capital------
Debt/Equity Ratio-0.00150.00130.0147-0.0408
Gross Margin100100100100100100
Operating Margin-369.9957-414.6134-484.6685-342.7399-31.9792-100.0108
EBIT Margin-369.9957-414.6134-484.6685-342.7399-31.9792-100.0108
EBITDA Margin-346.0821-170.2746-148.8738-338.5576-30.6484-98.5392
Pre-Tax Profit Margin-354.7183-438.6817-484.8408-342.59-31.7552-97.0898
Net Profit Margin-361.5171-411.1728-478.2442-353.9784-32.3355-97.6957
Asset Turnover0.10730.18870.17040.08430.53570.4636
Inventory Turnover Ratio------
Receiveable Turnover3.51542.31081.05612.71827.212324.9707
Days Sales In Receivables103.8284157.9572345.611134.279450.607714.6172
ROE - Return On Equity-45.0792-81.0786-117.8434-34.4297-20.666-54.478
Return On Tangible Equity-62.5844-113.6693-6892.607736.2654-24.0598-62.5115
ROA - Return On Assets-37.9595-71.5448-73.6558-28.8717-17.3227-45.2966
ROI - Return On Investment-45.0792-81.0786-117.8434-34.4233-20.666-54.478
Book Value Per Share2.97285.321964.7958139.827577.657386.281
Operating Cash Flow Per Share2.618743.4548-19.2037-12.508129.1362-1.7373
Free Cash Flow Per Share2.961543.3545-18.9034-12.680729.2057-1.6964